Compare CENT & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CENT | HTFL |
|---|---|---|
| Founded | 1955 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Consumer Specialties | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.2B |
| IPO Year | 1996 | 2025 |
| Metric | CENT | HTFL |
|---|---|---|
| Price | $43.76 | $42.17 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $50.00 | $38.20 |
| AVG Volume (30 Days) | 86.4K | ★ 948.3K |
| Earning Date | 05-06-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 57.41 | ★ 82.37 |
| EPS | ★ 2.84 | N/A |
| Revenue | ★ $3,129,100,000.00 | $176,034,000.00 |
| Revenue This Year | $1.60 | $27.66 |
| Revenue Next Year | $2.04 | $23.55 |
| P/E Ratio | $15.65 | ★ N/A |
| Revenue Growth | N/A | ★ 39.92 |
| 52 Week Low | $28.77 | $20.13 |
| 52 Week High | $46.97 | $41.22 |
| Indicator | CENT | HTFL |
|---|---|---|
| Relative Strength Index (RSI) | 50.83 | 83.53 |
| Support Level | $42.32 | $24.59 |
| Resistance Level | $45.77 | N/A |
| Average True Range (ATR) | 1.70 | 1.81 |
| MACD | -0.05 | 1.42 |
| Stochastic Oscillator | 57.59 | 94.88 |
Central Garden & Pet Co offers solutions that support healthier pets, greener lawns, and thriving gardens. Its products include dog and cat treats, chews, toys, beds, containment, grooming supplies, aquatics, small animal and bird supplies, equine and livestock products, insect control solutions, grass seed, wild bird feed, fertilizers, pest controls, live plants, and packet seeds, sold under brands such as Aqueon, Nylabone, Kaytee, Farnam, Pennington, Ferry Morse, Amdro, and Sevin. The company operates through two segments, Pet and Garden, and sells through retailers, independent stores, eCommerce channels, and professional markets. It has sales and distribution operations mainly across the United States, with additional facilities in Canada and Mexico.
HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.